Sakina Jeanne-Sayah
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
A Colon-Targeted Adsorbent (DAV132) Does Not Affect the Pharmacokinetics of Warfarin or Clonazepam in Healthy Subjects.
Journal: Clinical pharmacology in drug development
Published: September 30, 2020
Impact of oral amoxicillin and amoxicillin/clavulanic acid treatment on bacterial diversity and β-lactam resistance in the canine faecal microbiota.
Journal: The Journal of antimicrobial chemotherapy
Published: July 11, 2019
DAV131A Protects Hamsters from Lethal Clostridioides difficile Infection Induced by Fluoroquinolones.
Journal: Antimicrobial agents and chemotherapy
Published: June 12, 2019
Prevalence of Beta-Lactam and Quinolone/Fluoroquinolone Resistance in Enterobacteriaceae From Dogs in France and Spain-Characterization of ESBL/pAmpC Isolates, Genes, and Conjugative Plasmids.
Journal: Frontiers in veterinary science
Published: May 31, 2019
Impact of Acid-Reducing Agents on Gastrointestinal Physiology and Design of Biorelevant Dissolution Tests to Reflect These Changes.
Journal: Journal of pharmaceutical sciences
Published: May 30, 2019
Antibiotic-Induced Dysbiosis Predicts Mortality in an Animal Model of Clostridium difficile Infection.
Journal: Antimicrobial agents and chemotherapy
Published: May 04, 2018
Protection of Hamsters from Mortality by Reducing Fecal Moxifloxacin Concentration with DAV131A in a Model of Moxifloxacin-Induced Clostridium difficile Colitis.
Journal: Antimicrobial agents and chemotherapy
Published: March 14, 2017
Oral DAV131, a charcoal-based adsorbent, inhibits intestinal colonization by β-lactam-resistant Klebsiella pneumoniae in cefotaxime-treated mice.
Journal: Antimicrobial agents and chemotherapy
Published: August 21, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026